Agonists and knockdown of estrogen receptor β differentially affect invasion of triple-negative breast cancer cells in vitro

Effects of a combined treatment with tamoxifen and estrogen receptor β agonists on human breast cancer cell lines

(2013) Claus Lattrich et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

Distinct Phosphotyrosine-dependent Functions of the ShcA Adaptor Protein Are Required for Transforming Growth Factor β (TGFβ)-induced Breast Cancer Cell Migration, Invasion, and Metastasis

(2013) Jason J. Northey et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Transforming growth factor-β1 attenuates junctional adhesion molecule-A and contributes to breast cancer cell invasion

(2012) Yang Wang et al.   EUROPEAN JOURNAL OF CANCER

Astemizole Synergizes Calcitriol Antiproliferative Activity by Inhibiting CYP24A1 and Upregulating VDR: A Novel Approach for Breast Cancer Therapy

(2012) Janice García-Quiroz et al.   PLoS One

Estrogen receptor β agonists affect growth and gene expression of human breast cancer cell lines

(2012) Claus Lattrich et al.   STEROIDS

Estradiol inhibits chondrogenic differentiation of mesenchymal stem cells via nonclassic signaling

(2010) Zsuzsa Jenei-Lanzl et al.   ARTHRITIS AND RHEUMATISM

Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions Vitamin D pathways unbalanced in breast lesions

(2010) Nair Lopes et al.   BMC CANCER

Estrogen receptor β and the progression of prostate cancer: role of 5α-androstane-3β,17β-diol

(2010) Donatella Dondi et al.   ENDOCRINE-RELATED CANCER

Chondro/osteoblastic and cardiovascular gene modulation in human artery smooth muscle cells that calcify in the presence of phosphate and calcitriol or paricalcitol

(2010) V. Shalhoub et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

CdGAP is required for transforming growth factor β- and Neu/ErbB-2-induced breast cancer cell motility and invasion

(2010) Y He et al.   ONCOGENE

Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells

(2009) Oliver Treeck et al.   BREAST CANCER RESEARCH AND TREATMENT

Mitochondrial Dysfunction and Reactive Oxygen Species Imbalance Promote Breast Cancer Cell Motility through a CXCL14-Mediated Mechanism

(2009) H. Pelicano et al.   CANCER RESEARCH

Endogenous tenascin-C enhances glioblastoma invasion with reactive change of surrounding brain tissue

(2009) Eishu Hirata et al.   CANCER SCIENCE

Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes

(2009) E. A. Rakha et al.   CLINICAL CANCER RESEARCH

Expression of estrogen receptor β increases integrin α1 and integrin β1 levels and enhances adhesion of breast cancer cells

(2009) Karolina Lindberg et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Estrogen receptor-β expression in invasive breast cancer in relation to molecular phenotype: results from the Nurses' Health Study

(2009) Jonathan D Marotti et al.   MODERN PATHOLOGY

Progestin regulates chemokine (C-X-C motif) ligand 14 transcript level in human endometrium

(2009) N. M. Mokhtar et al.   MOLECULAR HUMAN REPRODUCTION

Estrogen receptor-β status influences clinical outcome of triple-negative breast cancer

(2009) Goi Sakamoto et al.   Breast Cancer

How basal are triple-negative breast cancers?

(2008) François Bertucci et al.   INTERNATIONAL JOURNAL OF CANCER

Signaling through ShcA Is Required for Transforming Growth Factor  - and Neu/ErbB-2-Induced Breast Cancer Cell Motility and Invasion

(2008) J. J. Northey et al.   MOLECULAR AND CELLULAR BIOLOGY

Liquiritigenin is a plant-derived highly selective estrogen receptor β agonist

(2007) Jennifer E. Mersereau et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY